⌘K

Login Start Free

Home/Filings/4/0001144204-12-003983

4//SEC Filing

Lyons C Neil 4

Accession 0001144204-12-003983

CIK 0001318641other

View on SEC.gov Company Profile

Filed

Jan 24, 7:00 PM ET

Accepted

Jan 25, 9:21 PM ET

Size

5.4 KB

Accession

0001144204-12-003983

Insider Transaction Report

Form 4

Period: 2012-01-23

CLEVELAND BIOLABS INCCBLI

Chief Financial Officer

Transactions

Award
Employee Stock Options (Right to Buy)
2012-01-23+18,750→ 18,750 total
Exercise: $3.35From: 2012-01-23Exp: 2022-01-23→ Common Stock (18,750 underlying)

Footnotes (1)

[F1]On January 23, 2012, with the approval of the Compensation Committee, Cleveland BioLabs, Inc. issued stock options to Mr. Lyons per the 2011 Executive Compensation Plan.

Documents

1 file

4
v300239_form4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

CLEVELAND BIOLABS INC

CIK 0001318641

Entity typeother

Related Parties

1

filerCIK 0001324648

Filing Metadata

Form type: 4
Filed: Jan 24, 7:00 PM ET
Accepted: Jan 25, 9:21 PM ET
Size: 5.4 KB

View on SEC.gov